Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma

Daniel Webb; W. R. Esmieu; K. L. Jones; R. J.  Tinson; N. Macabuag; R.  Bago; S. Clifton; L. Milanos; Laura Paterson; David Lindsay; William Kerr

Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma

Daniel Webb, W. R. Esmieu, K. L. Jones, R. J. Tinson, N. Macabuag, R. Bago, S. Clifton, L. Milanos, Laura Paterson, David Lindsay, William Kerr

Pure And Applied Chemistry

Research output: Contribution to conference › Presentation/Speech

Original language	English
Publication status	Published - 16 Oct 2024
Event	Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4 - Cranfield University, Bedford, United Kingdom Duration: 15 Oct 2024 → 16 Oct 2024

Conference

Conference	Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4
Country/Territory	United Kingdom
City	Bedford
Period	15/10/24 → 16/10/24

Keywords

kinase 2 degradation
pontine glioma

Cite this

Webb, D., Esmieu, W. R., Jones, K. L., Tinson, R. J., Macabuag, N., Bago, R., Clifton, S., Milanos, L., Paterson, L., Lindsay, D., & Kerr, W. (2024). Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma. Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4, Bedford, United Kingdom.

@conference{17da012f4c3546e9859d59fc946db1ca,

title = "Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma",

keywords = "kinase 2 degradation, pontine glioma",

author = "Daniel Webb and Esmieu, {W. R.} and Jones, {K. L.} and Tinson, {R. J.} and N. Macabuag and R. Bago and S. Clifton and L. Milanos and Laura Paterson and David Lindsay and William Kerr",

year = "2024",

month = oct,

day = "16",

language = "English",

note = "Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4 ; Conference date: 15-10-2024 Through 16-10-2024",

}

Webb, D, Esmieu, WR, Jones, KL, Tinson, RJ, Macabuag, N, Bago, R, Clifton, S, Milanos, L, Paterson, L, Lindsay, D & Kerr, W 2024, 'Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma', Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4, Bedford, United Kingdom, 15/10/24 - 16/10/24.

Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma. / Webb, Daniel; Esmieu, W. R.; Jones, K. L. et al.
2024. Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4, Bedford, United Kingdom.

Research output: Contribution to conference › Presentation/Speech

TY - CONF

T1 - Activin receptor-like kinase 2 degradation as a novel therapeutic strategy towards the treatment of diffuse intrinsic pontine glioma

AU - Webb, Daniel

AU - Esmieu, W. R.

AU - Jones, K. L.

AU - Tinson, R. J.

AU - Macabuag, N.

AU - Bago, R.

AU - Clifton, S.

AU - Milanos, L.

AU - Paterson, Laura

AU - Lindsay, David

AU - Kerr, William

PY - 2024/10/16

Y1 - 2024/10/16

KW - kinase 2 degradation

KW - pontine glioma

M3 - Presentation/Speech

T2 - Biological and Medicinal Chemistry Sector (RSC-BMCS) – Society of Chemical Industry (SCI) Targeting Protein Degradation 4

Y2 - 15 October 2024 through 16 October 2024

ER -